Susquehanna International Group’s Stemline Therapeutics, Inc. STML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-14,600
| Closed | -$71K | – | 11422 |
|
|
2020
Q1 | $71K | Sell |
14,600
-100
| -0.7% | -$648 | ﹤0.01% | 9515 |
|
|
2019
Q4 | $156K | Sell |
14,700
-58,100
| -80% | -$577K | ﹤0.01% | 8927 |
|
|
2019
Q3 | $758K | Sell |
72,800
-35,700
| -33% | -$467K | ﹤0.01% | 6329 |
|
|
2019
Q2 | $1.66M | Sell |
108,500
-24,800
| -19% | -$359K | ﹤0.01% | 4541 |
|
|
2019
Q1 | $1.71M | Sell |
133,300
-69,600
| -34% | -$787K | ﹤0.01% | 3998 |
|
|
2018
Q4 | $1.93M | Buy |
202,900
+3,800
| +2% | +$49.3K | ﹤0.01% | 3578 |
|
|
2018
Q3 | $3.31M | Buy |
199,100
+30,200
| +18% | +$484K | ﹤0.01% | 3223 |
|
|
2018
Q2 | $2.71M | Buy |
168,900
+86,000
| +104% | +$1.54M | ﹤0.01% | 3524 |
|
|
2018
Q1 | $1.27M | Buy |
82,900
+50,900
| +159% | +$794K | ﹤0.01% | 4752 |
|
|
2017
Q4 | $499K | Sell |
32,000
-20,700
| -39% | -$277K | ﹤0.01% | 6649 |
|
|
2017
Q3 | $585K | Buy |
52,700
+36,500
| +225% | +$343K | ﹤0.01% | 6255 |
|
|
2017
Q2 | $149K | Sell |
16,200
-41,100
| -72% | -$343K | ﹤0.01% | 8501 |
|
|
2017
Q1 | $490K | Buy |
57,300
+28,000
| +96% | +$255K | ﹤0.01% | 6522 |
|
|
2016
Q4 | $314K | Buy |
29,300
+13,600
| +87% | +$164K | ﹤0.01% | 7897 |
|
|
2016
Q3 | $170K | Buy |
+15,700
| New | +$128K | ﹤0.01% | 7699 |
|
|
2016
Q2 | – | Sell |
-12,200
| Closed | -$57K | – | 9661 |
|
|
2016
Q1 | $57K | Buy |
+12,200
| New | +$59.6K | ﹤0.01% | 8631 |
|
|
2015
Q4 | – | Sell |
-45,100
| Closed | -$398K | – | 10235 |
|
|
2015
Q3 | $398K | Buy |
+45,100
| New | +$473K | ﹤0.01% | 7557 |
|
|
2014
Q4 | – | Sell |
-16,000
| Closed | -$199K | – | 10303 |
|
|
2014
Q3 | $199K | Buy |
+16,000
| New | +$197K | ﹤0.01% | 8688 |
|
Susquehanna International Group's STML Position: Q2 2020 in Review
Susquehanna International Group sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 59,168 shares — an estimated $286K sold.
Susquehanna International Group first reported a position in STML in Q4 2013 and held it in 19 quarters. The position peaked at $1.85M in Q4 2018. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.
- Susquehanna International Group reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
- Susquehanna International Group sold 59,168 Stemline Therapeutics, Inc. shares in Q2 2020, an estimated $286K.
- Susquehanna International Group first reported a position in Stemline Therapeutics, Inc. in Q4 2013 and held it in 19 quarters.
- Susquehanna International Group's Stemline Therapeutics, Inc. position peaked at $1.85M in Q4 2018.
- 0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.
Based on Susquehanna International Group's 13F filing for Q2 2020, filed 14 Aug 2020.